Literature DB >> 33372449

Clitoromegaly caused by ovarian stimulation in a preterm newborn: ovarian hyperstimulation syndrome of preterm babies.

Elvan Bayramoğlu1, Şenay Savaş Erdeve1, Betül Emine Derinkuyu2, İstemi Han Çelik3, Semra Çetinkaya1, Zehra Aycan1.   

Abstract

BACKGROUND: Preterm ovarian hyperstimulation syndrome (POHS) is an uncommon disorder characterized by prematurity, hypogastric and upper leg swelling, high serum estradiol and gonadotropin levels, and ovarian cysts. Immaturity of the gonadal axis is accepted as the cause. But still, other etiological factors are suspected. CASE: A preterm baby who was born at 24 gestational weeks was referred to our clinic for ambiguous genitalia on day 118 of life. Labia majora and clitoris was edematous. Clitoris length was 1.5 cm. On laboratory evaluation: 17OH-Progesterone: 1.84 ng/ml, dehydroepiandrosterone sulphate (DHEA-S): 139 μg/dl, total testosterone (T.T): 88 ng/dl, luteinizing hormone (LH): 22.5 mIU/l, Follicle stimulating hormone (FSH): 15.7 mIU/l, estradiol (E2): 447 pg/ml. Karyotype analysis was 46, XX. There was a 25x14x12 mm ovarian cyst detected on ultrasound. On follow-up, E2 levels and cyst size increased, and there was 4 mm pericardial effusion on echocardiography at the time.
CONCLUSION: In this paper, we present a case with POHS and to discuss possible pathophysiological mechanisms and treatment. This is the first case of POHS developing pericardial effusion.

Entities:  

Keywords:  clitoromegaly; ovarian cyst; pericardial effusion; preterm ovarian hyperstimulation syndrome

Year:  2020        PMID: 33372449     DOI: 10.24953/turkjped.2020.06.022

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  1 in total

1.  A Case with Preterm Ovarian Hyperstimulation Syndrome: The Importance of the Physical Examination in Differential Diagnosis of Ambiguous Genitalia.

Authors:  Ayşe Anık; Reyhan Deveci Sevim; Suzan Şahin; Abdullah Barış Akcan; Tolga Ünüvar; Ahmet Anık
Journal:  Turk Arch Pediatr       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.